v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:          
Net income $ 178,344 $ 1,171 $ 347,395 $ 139,074  
Adjustments to reconcile net income to cash provided by (used in) operating activities:          
Change in future policy benefits and other policy liabilities     93,709 27,932  
Deferral of policy acquisition costs     (275,342) (271,170)  
Amortization of deferred policy acquisition costs 80,043 73,643 158,592 145,692  
Change in income taxes     (49,947) (59,157)  
Investment (gains) losses 2,866 99 2,109 (1,206)  
Accretion and amortization of investments     (1,579) (1,863)  
Depreciation and amortization     10,024 14,483  
Change in reinsurance recoverables     88,798 110,508  
Change in agent balances, due premiums and other receivables     (12,825) (14,793)  
Change in renewal commissions receivable     1,265 19,237  
Trading securities sold, matured, or called (acquired), net     123 15,160  
Share-based compensation     15,477 15,668  
Impairment of goodwill and other long-lived assets     0 253,607  
Gain on insurance proceeds received from acquisition representation and warranty policy   (50,000) 0 (50,000)  
Change in other operating assets and liabilities, net     (17,757) 41,010  
Net cash provided by (used in) operating activities     360,042 384,182  
Available-for-sale investments sold, matured or called:          
Fixed-maturity securities — sold     1,329 1,382  
Fixed-maturity securities — matured or called     235,712 215,444  
Short-term investments — matured or called     0 268  
Equity securities — sold     26 0  
Equity securities — matured or called     1,829 4,272  
Available-for-sale investments acquired:          
Fixed-maturity securities     (326,997) (315,271)  
Equity securities — acquired     (112) 0  
Purchases of property and equipment and other investing activities, net     (12,258) (12,604)  
Cash collateral received (returned) on loaned securities, net     (2,609) (8,789)  
Sales (purchases) of short-term investments using securities lending collateral, net     2,609 8,789  
Insurance Proceeds Received from Acquisition Representation and Warranty Policy     0 50,000  
Net cash provided by (used in) investing activities     (100,471) (56,509)  
Cash flows from financing activities:          
Dividends paid     (68,945) (52,091)  
Common stock repurchased     (251,008) (251,821)  
Tax withholdings on share-based compensation     (8,655) (7,491)  
Finance leases     (137) (130)  
Net cash provided by (used in) financing activities     (328,745) (311,533)  
Effect of foreign exchange rate changes on cash     2,551 (1,996)  
Change in cash and cash equivalents     (66,623) 14,144  
Cash and cash equivalents, beginning of period     687,821 613,148 $ 613,148
Cash and cash equivalents, end of period $ 621,198 $ 627,292 $ 621,198 $ 627,292 $ 687,821